ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,764,000 | -95.1% | 80,000 | -93.9% | 0.02% | -95.8% |
| Q3 2020 | $97,974,000 | +56.3% | 1,309,986 | +31.6% | 0.50% | +22.7% |
| Q2 2020 | $62,676,000 | +348.3% | 995,644 | +199.1% | 0.41% | +258.8% |
| Q1 2020 | $13,981,000 | -5.3% | 332,885 | +2.4% | 0.11% | +46.2% |
| Q4 2019 | $14,769,000 | +109.5% | 325,163 | +111.1% | 0.08% | +81.4% |
| Q3 2019 | $7,049,000 | +32.5% | 154,019 | +69.7% | 0.04% | +53.6% |
| Q2 2019 | $5,320,000 | -50.3% | 90,735 | -67.0% | 0.03% | -46.2% |
| Q4 2018 | $10,715,000 | -75.7% | 275,100 | -71.3% | 0.05% | -71.4% |
| Q3 2018 | $44,037,000 | -26.1% | 956,900 | -30.0% | 0.18% | -23.5% |
| Q2 2018 | $59,619,000 | +347.4% | 1,367,400 | +305.3% | 0.24% | +325.0% |
| Q1 2018 | $13,327,000 | +134.6% | 337,400 | +101.8% | 0.06% | +124.0% |
| Q4 2017 | $5,680,000 | -43.0% | 167,200 | -57.2% | 0.02% | -44.4% |
| Q3 2017 | $9,973,000 | – | 391,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |